UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

________________________

FORM 8-K

________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of Earliest event Reported): ~~November~~March 320, ~~2023~~2024

Wearable Health Solutions, Inc.

(Exact name of registrant as specified in its charter)

Nevada	000-56368	26-3534190
(State of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

~~2901 W~~10525 N. ~~Coast~~Port ~~Highway~~Washington Road, Suite ~~200~~204,

~~Newport Beach~~Mequon, CAWI 53092

92663

(Address of principal executive offices)

Phone: (~~949~~877) ~~270 7460~~639-2929

(Registrant’s telephone number)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Not applicable		Not applicable		Not applicable

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1 8.01. ~~Entry~~Other ~~into a Material Definitive Agreement~~Events.

OnMarch ~~November 3~~20, ~~2023~~2024, Wearable Health Solutions, Inc. a Nevada corporation (the “Company” or “WHSI”) ~~entered~~hereby ~~into~~discloses a ~~Promissory~~material ~~Note~~disruption affecting ~~Agreement~~approximately ~~(the~~2000 ~~“Promissory~~active ~~Note”) with~~units of its ~~president~~Canadian ~~Peter~~3G ~~Pizzino (“Noteholder”)~~devices, ~~pursuant to~~ which ~~the~~were ~~Company~~previously ~~issued~~connected to the ~~Noteholder,~~Bell onCanada ~~November~~network. ~~3, 2023,~~This ~~Secured~~disruption ~~Note~~arose indue anto ~~aggregate~~ongoing ~~principal~~negotiations ~~amount~~with ofBell ~~$279,940~~Canada ~~(the~~regarding ~~“Notes”)~~significant overcharges, ~~consisting~~the ofresulting ~~gross~~owed ~~proceeds~~payments ofand ~~loans of $279,940,~~then ~~that~~the ~~were~~Material ~~made~~Disruption ~~in cash by Noteholder~~ to ~~the~~Canadian ~~Company~~3G ~~over~~customers ~~the~~and ~~past~~proposed ~~year~~increases ~~used~~in pricing for ~~operations,~~new ~~which~~service ~~Note shall not be convertible into the Company’s common stock, par value $0~~plans.~~0001 per share.~~

~~The~~Following ~~Note~~an ~~accrues~~impasse ~~interest~~in atnegotiations, ~~the~~Bell ~~rate of 3% per~~Canada ~~annum~~proposed ~~and~~a ~~matures~~new oncontract ~~October~~with 7,increased ~~2024. Interest~~pricing onthat ~~the~~WHSI ~~Note~~deemed iseconomically ~~payable in cash~~unsustainable. ~~Upon~~Consequently, ~~the~~there ~~occurrence~~was ofa ansuspension ~~event~~ of ~~default~~service, ~~interest~~ ~~accrues~~prompting atWHSI ~~15%~~to ~~per~~reassess ~~annum.~~its ~~The~~agreements ~~Note contains customary default provisions, including provisions for potential acceleration,~~ and ~~covenants, including negative covenants regarding additional indebtedness and dividends~~operations. ~~The Company may only prepay the Note with the prior written consent of the respective Noteholder thereof.~~

~~Contemporaneously~~As ~~with~~a ~~the~~result ~~execution and delivery~~ of ~~the~~subsequent ~~Promissory Note Agreement~~discussions, onWHSI ~~November 3, 2023, the Company~~ and Bell ~~certain~~Canada ofhave ~~its~~reached ~~wholly-owned subsidiaries entered into~~ a ~~Security Agreement~~new ~~(the~~agreement. ~~“Security~~Under ~~Agreement”)~~this ~~and Satisfaction Agreement (“Satisfaction Agreement”) with Peter Pizzino~~agreement, as ~~collateral~~affected ~~agent~~dealers onwill ~~behalf~~have of the ~~Noteholder,~~opportunity ~~pursuant~~ to ~~which~~open ~~the~~accounts ~~Noteholder~~directly ~~has been granted a first-priority security interest~~with inBell ~~any~~Canada and ~~all~~enter ~~assets~~into ofindividual ~~the~~service ~~Company~~plans. inAdditionally, ~~the~~WHSI ~~event~~anticipates ofa ~~default~~reduction orin ~~demand~~billing ~~and~~for ~~such~~airtime ~~subsidiaries~~services ~~securing~~as ~~(i) an aggregate principal amount~~part of ~~$279,940 in a Note in~~ the ~~Company~~new arrangement. The ~~Satisfaction~~Canadian ~~Agreement~~3G ~~that~~devices ~~the~~are ~~Promissory~~currently ~~Note~~active ~~satisfies all of the Noteholder debt~~ and ~~that the~~operating ~~Noteholder debt is satisfied in full~~ as ~~to the $279,940 that was paid into the Company~~intended.

The ~~Promissory~~reduction ~~Note~~in ~~Agreement~~revenue ~~contains~~resulting ~~customary representations,~~from ~~warranties and covenants, including covenants, subject to certain exceptions, for as long as a Noteholder holds any outstanding~~these ~~Securities,~~units ~~such~~poses ~~as,~~challenges ~~Notes, Warrants, shares underlying the exercise of the Warrants, Conversion Shares, or any additional shares~~ to ~~be issued~~WHSI's tobusiness ~~the~~model ~~Noteholders, the Company shall amend the terms~~ and ~~conditions~~operations. ofIn ~~the~~light ~~Purchase Agreement and the transactions contemplated thereby with respect to such Noteholder to give such Noteholder the benefit~~ of ~~any~~these ~~terms~~developments, orWHSI's ~~conditions~~management ~~under~~has ~~which~~made the ~~Company agrees~~decision to ~~issue~~pause ~~or sell~~ any ~~Common~~production ~~Stock~~activities orrelated ~~Common Stock equivalents that are more favorable~~ to anits ~~investor~~new ~~than~~product, the ~~terms~~iHelp ~~and conditions granted to such Noteholder under the Purchase Agreement and the transactions contemplated thereby, within five (5) trading days after disclosure of such issuance or sale~~MAX.

~~The~~This ~~foregoing~~disruption ~~description~~and issubsequent ~~qualified~~agreement ~~in its~~with ~~entirety~~Bell byCanada ~~reference~~may tohave ~~the~~financial ~~full~~implications ~~text~~for ofWHSI in the ~~form~~short ofterm. ~~Notes,~~Management ~~the~~is ~~Security~~actively ~~Agreement~~monitoring ~~and~~ the ~~Satisfaction~~situation ~~Agreement,~~and aswill ~~applicable, a copy~~provide offurther ~~each~~updates ~~of which is filed~~ as ~~Exhibit 4~~necessary.~~1, Exhibit 10.1, and Exhibit 10.2 hereto, respectively, and each of which is incorporated herein by reference.~~

~~Item~~ 2~~.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.~~

~~The information set forth above in Item 1.01 of this Report is incorporated by reference herein.~~SIGNATURE

2Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

	Wearable Health Solutions, Inc.


Date: March 22, 2024	By: /s/ Peter Pizzino
	Peter Pizzino
	Chief Executive Officer
	Principal Executive Officer

On November 8, 2023, Mr. Harrysen Mittler resigned from the capacity of CEO and as a Director for the Company. The resignation of Mr. Mittler- was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Mr. Peter Pizzino our current President and Director will take over as the Company’s CEO.3

Item 9.01 Financial Statements and Exhibits

Exhibit No.		Description
4.1		Form of Secured Convertible Note by and between the Company and Purchasers, dated November 3, 2023.
10.1		Security Agreement by and among the Company, Peter Pizzino, as collateral agent, and the Purchasers, dated November 3, 2023.
10.2		Satisfaction Agreement by and between the Company and Peter Pizzino, dated November 3, 2023.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Wearable Health Solutions, Inc.
Date: November 16, 2023	By: /s/ Peter Pizzino
	Peter Pizzino
	CEO

Filing Compare · WEARABLE HEALTH SOLUTIONS, INC.